Evaluation of ark make investments trades exhibits ARK shifting towards healthcare AI as Tempus AI turns into a prime holding amid trims of Meta and Roku.
In a recent spherical of ARK Make investments trades, Cathie Wooden rebalanced a number of flagship ETFs by chopping publicity to huge tech and including to a high-conviction healthcare AI title.
ARK cuts Meta place after trial and layoffs
Cathie Wooden‘s ARK Make investments trimmed its Meta place on Wednesday, March 25, redirecting capital towards healthcare-focused synthetic intelligence. Nevertheless, the transfer got here as Meta confronted each authorized and operational headwinds in america.
Throughout three funds, ARK offered 3,578 Meta shares, price about $2.1 million based mostly on the inventory’s closing value. Furthermore, after this sale, the ARK Innovation ETF now holds roughly 105,000 Meta shares valued at near $63 million, representing about 1% of the fund.
A jury discovered Meta and Google’s YouTube negligent in a landmark social-media dependancy trial, ruling that their merchandise harmed kids and youngsters. Each firms mentioned they plan to attraction. That mentioned, Meta additionally launched a brand new government pay plan concentrating on a 500% inventory enhance and a possible $9 trillion valuation by 2031.
The corporate confirmed to Barron’s that it was shedding a number of hundred staff throughout its gross sales, recruiting, and digital actuality divisions. Nevertheless, regardless of the authorized setback and layoffs, Meta shares ended the day up simply 0.3%, signaling restricted speedy market response.
ARK trims Roku and different expertise names
Alongside Meta, ARK additional lower its publicity to Roku. The agency offered 95,090 Roku shares throughout its ARKK, ARKW, and ARKF funds, for a complete of round $9.1 million. Furthermore, this transfer adopted a large Roku sale the day gone by, on March 24.
Different important gross sales included 30,174 shares of Teradyne for roughly $9.7 million, reflecting additional de-risking in {hardware} and testing names. ARK additionally offered 205,019 shares of Bullish throughout three ETFs, price about $7.7 million. The agency has been promoting Bullish constantly over the previous week, signaling a transparent rotation away from that holding.
Further disposals on Wednesday featured 62,393 shares of Kratos Protection at roughly $4.8 million in worth, and 27,647 shares of Natera price about $5.4 million. That mentioned, ARK’s total technique seems much less about broad risk-off positioning and extra about reallocating capital into focused development themes.
ARK’s huge wager on Tempus AI
On the shopping for aspect, Tempus AI dominated the day’s transactions. ARK bought 84,939 Tempus AI shares by means of its ARKK and ARKG ETFs, spending round $4.1 million. Nevertheless, the brand new allocation got here even because the inventory remained underneath strain in public markets.
Tempus AI fell 4.2% on Wednesday and is down 21% to date in 2026, making ARK’s transfer appear to be a deliberate dip-buy. Furthermore, ARK Innovation ETF now holds round 6.3 million Tempus AI shares price greater than $294 million, turning the corporate into one in all its highest-conviction positions.
That makes Tempus AI the fund’s third-largest holding, behind Tesla and Crispr Therapeutics, accounting for roughly 5% of the entire portfolio. This dimension clearly underscores Wooden’s concentrate on healthcare AI as a long-term disruptive theme moderately than a short-term commerce.
Why ARK is leaning into healthcare AI
Tempus AI is a healthcare expertise firm that makes use of synthetic intelligence to handle and interpret medical information, with a specific concentrate on most cancers care. Nevertheless, not like pure software program performs, its mannequin sits on the intersection of knowledge infrastructure, diagnostics, and medical resolution help.
Strategically, this push into healthcare AI aligns with ARK’s thesis that genomic and>A sample in current ark make investments trades
Current transaction information exhibits that ark make investments trades are a part of a broader sample moderately than remoted strikes. Over a number of consecutive days, ARK has been decreasing positions in Roku, Teradyne, and Bullish whereas steadily constructing its stake in Tempus AI. That mentioned, the agency shouldn’t be abandoning different innovation themes totally.
Smaller purchases on Wednesday included shares of Archer Aviation, Beam Therapeutics, and a number of other different high-growth names. Furthermore, the ARK Innovation ETF itself closed the day up 1.3%, suggesting buyers stay assured in Wooden’s long-term disruptive innovation technique regardless of important portfolio churn.
In abstract, ARK’s newest rebalancing on March 25 exhibits a transparent rotation away from social-media and streaming shares towards healthcare-focused synthetic intelligence, with Tempus AI rising as a central pillar of the agency’s 2026 innovation wager.
